AUPO589197A0 - Enhancement of immune response using targeting molecules - Google Patents

Enhancement of immune response using targeting molecules

Info

Publication number
AUPO589197A0
AUPO589197A0 AUPO5891A AUPO589197A AUPO589197A0 AU PO589197 A0 AUPO589197 A0 AU PO589197A0 AU PO5891 A AUPO5891 A AU PO5891A AU PO589197 A AUPO589197 A AU PO589197A AU PO589197 A0 AUPO589197 A0 AU PO589197A0
Authority
AU
Australia
Prior art keywords
enhancement
immune response
targeting molecules
targeting
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO5891A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Walter and Eliza Hall Institute of Medical Research
CSL Ltd
University of Melbourne
QIMR Berghofer Medical Research Institute
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Walter and Eliza Hall Institute of Medical Research
Queensland Institute of Medical Research QIMR
CSL Ltd
University of Melbourne
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Walter and Eliza Hall Institute of Medical Research, Queensland Institute of Medical Research QIMR, CSL Ltd, University of Melbourne, Biotech Australia Pty Ltd filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPO5891A priority Critical patent/AUPO589197A0/en
Publication of AUPO589197A0 publication Critical patent/AUPO589197A0/en
Priority to PCT/AU1998/000208 priority patent/WO1998044129A1/en
Priority to JP54098998A priority patent/JP4382163B2/en
Priority to EP98910530A priority patent/EP0972054B1/en
Priority to DE69840326T priority patent/DE69840326D1/en
Priority to AT98910530T priority patent/ATE417112T1/en
Priority to AU64902/98A priority patent/AU728962B2/en
Priority to NZ500151A priority patent/NZ500151A/en
Priority to CA2285692A priority patent/CA2285692C/en
Priority to ZA982608A priority patent/ZA982608B/en
Assigned to COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, CSL LIMITED, UNIVERSITY OF MELBOURNE, THE, WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH, THE, COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH, THE reassignment COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION Assignment by Applicant under S 113 Assignors: BIOTECH AUSTRALIA PTY LIMITED, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH, THE, CSL LIMITED, UNIVERSITY OF MELBOURNE, THE, WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH, THE
Priority to US10/185,318 priority patent/US7423016B2/en
Priority to US10/185,799 priority patent/US7423023B2/en
Abandoned legal-status Critical Current

Links

AUPO5891A 1997-03-27 1997-03-27 Enhancement of immune response using targeting molecules Abandoned AUPO589197A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AUPO5891A AUPO589197A0 (en) 1997-03-27 1997-03-27 Enhancement of immune response using targeting molecules
CA2285692A CA2285692C (en) 1997-03-27 1998-03-26 Enhancement of immune response using targeting molecules
AU64902/98A AU728962B2 (en) 1997-03-27 1998-03-26 Enhancement of immune response using targeting molecules
JP54098998A JP4382163B2 (en) 1997-03-27 1998-03-26 Enhancement of immune response using targeting molecules
EP98910530A EP0972054B1 (en) 1997-03-27 1998-03-26 Enhancement of immune response using targeting molecules
DE69840326T DE69840326D1 (en) 1997-03-27 1998-03-26 INCREASING IMMUNE RESPONSE USING TARGETED MOLECULES
AT98910530T ATE417112T1 (en) 1997-03-27 1998-03-26 ENHANCEMENT OF THE IMMUNE RESPONSE USING TARGETED MOLECULES
PCT/AU1998/000208 WO1998044129A1 (en) 1997-03-27 1998-03-26 Enhancement of immune response using targeting molecules
NZ500151A NZ500151A (en) 1997-03-27 1998-03-26 A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
ZA982608A ZA982608B (en) 1997-03-27 1998-03-27 Enhancement of immune response using targeting molecules
US10/185,318 US7423016B2 (en) 1997-03-27 2002-06-28 Immune response targeting molecules
US10/185,799 US7423023B2 (en) 1997-03-27 2002-06-28 Enhancement of immune response using targeting molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO5891A AUPO589197A0 (en) 1997-03-27 1997-03-27 Enhancement of immune response using targeting molecules

Publications (1)

Publication Number Publication Date
AUPO589197A0 true AUPO589197A0 (en) 1997-04-24

Family

ID=3800192

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO5891A Abandoned AUPO589197A0 (en) 1997-03-27 1997-03-27 Enhancement of immune response using targeting molecules

Country Status (2)

Country Link
AU (1) AUPO589197A0 (en)
ZA (1) ZA982608B (en)

Also Published As

Publication number Publication date
ZA982608B (en) 1998-10-08

Similar Documents

Publication Publication Date Title
AUPO625497A0 (en) Analysis of molecules
AU3095095A (en) Rna component of telomerase
AU6609196A (en) Verification of barcodes
AU8800598A (en) B7-binding molecules for treating immune diseases
AU1416499A (en) Novel molecules of the follistatin-related protein family and uses therefor
AU9222698A (en) Novel molecules of the tnfr-ligand-related protein family and uses thereof
AU1184399A (en) Therapeutic molecules
AU5874798A (en) Vaccination methods and molecules
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU6303898A (en) Component of bromelain
AU4201000A (en) Molecules of the immune system
AU1991799A (en) Molecules associated with the human suppressor of fused gene
AUPO589197A0 (en) Enhancement of immune response using targeting molecules
AUPP183098A0 (en) Enhancement of immune response using targeting molecules
AU8102498A (en) Preparation of diaryl-benzopyrans
AU6034298A (en) Two human homologues of galectin-5
AU5386498A (en) Enhancement phalloplasty
AUPO852797A0 (en) Enhancement phalloplasty
AUPN240795A0 (en) Improved fixing assembly
AU7457098A (en) Gene targeting and sibling-selection to generate mutant individuals
AU1151899A (en) Bonding molecules against receptor-ligand-complexes
AU8393898A (en) Sr-bi nucleic acids and uses therefor
AU6833998A (en) Personal grounding
AU4062397A (en) Protein targeting to glycogen
AU6074000A (en) Human immune response molecules